{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:00:52Z","timestamp":1790125252351,"version":"4.0.1"},"reference-count":66,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026109","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:16:42Z","timestamp":1780885002000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling"],"prefix":"10.3724","author":[{"given":"Zhihui","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","volume":"476","author":"Xu S","year":"2020","unstructured":"Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett, 2020, 476: 1-12.","journal-title":"Cancer Lett"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/s41591-024-03224-y","volume":"30","author":"Lee S","year":"2024","unstructured":"Lee S, Weiss T, B\u00fchler M, Mena J, Lottenbach Z, Wegmann R, Sun M. High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity. Nat Med, 2024, 30: 3196-3208.","journal-title":"Nat Med"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-025-60074-z","volume":"16","author":"Nejo T","year":"2025","unstructured":"Nejo T, Krishna S, Yamamichi A, Lakshmanachetty S, Jimenez C, Lee KY, Baker DL. Glioma-neuronal circuit remodeling induces regional immunosuppression. Nat Commun, 2025, 16:","journal-title":"Nat Commun"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"Ohgaki H","year":"2005","unstructured":"Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol, 2005, 64: 479-489.","journal-title":"J Neuropathol Exp Neurol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","volume":"130","author":"Krex D","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M. Long-term survival with glioblastoma multiforme. Brain, 2007, 130: 2596-2606.","journal-title":"Brain"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/neuonc\/noz189","volume":"22","author":"Yu-Ju Wu C","year":"2020","unstructured":"Yu-Ju Wu C, Chen CH, Lin CY, Feng LY, Lin YC, Wei KC, Huang CY. CCL5 of glioma-associated microglia\/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2. Neuro-Oncology, 2020, 22: 253-266.","journal-title":"Neuro-Oncology"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"Chen J","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 2012, 488: 522-526.","journal-title":"Nature"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/neuonc\/nos337","volume":"15","author":"Towner RA","year":"2013","unstructured":"Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak Iii RS. Regression of glioma tumor growth in F98 and U87 rat glioma models by the nitrone OKN-007. Neuro-Oncology, 2013, 15: 330-340.","journal-title":"Neuro-Oncology"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"2401383","DOI":"10.1002\/adfm.202401383","volume":"34","author":"Hu Y","year":"2024","unstructured":"Hu Y, Zhou L, Wang Z, Ye Z, Liu H, Lu Y, Qi Z. Assembled embedded 3D hydrogel system for asynchronous drug delivery to inhibit postoperative recurrence of malignant glioma and promote neurological recovery. Adv Funct Mater, 2024, 34:","journal-title":"Adv Funct Mater"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"Winkler F","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH. Cancer neuroscience: state of the field, emerging directions. Cell, 2023, 186: 1689-1707.","journal-title":"Cell"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"Mancusi R","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature, 2023, 618: 467-479.","journal-title":"Nature"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"Suv\u00e0 ML","year":"2014","unstructured":"Suv\u00e0 ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell, 2014, 157: 580-594.","journal-title":"Cell"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"Lee JH","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature, 2018, 560: 243-247.","journal-title":"Nature"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"Venkatesh HS","year":"2019","unstructured":"Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M, Tam LT. Electrical and synaptic integration of glioma into neural circuits. Nature, 2019, 573: 539-545.","journal-title":"Nature"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"Taylor KR","year":"2023","unstructured":"Taylor KR, Barron T, Hui A, Spitzer A, Yal\u00e7in B, Ivec AE, Geraghty AC. Glioma synapses recruit mechanisms of adaptive plasticity. Nature, 2023, 623: 366-374.","journal-title":"Nature"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41586-023-06267-2","volume":"619","author":"Huang-Hobbs E","year":"2023","unstructured":"Huang-Hobbs E, Cheng YT, Ko Y, Luna-Figueroa E, Lozzi B, Taylor KR, McDonald M. Remote neuronal activity drives glioma progression through SEMA4F. Nature, 2023, 619: 844-850.","journal-title":"Nature"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1523\/JNEUROSCI.1589-18.2018","volume":"39","author":"Caragher SP","year":"2019","unstructured":"Caragher SP, Shireman JM, Huang M, Miska J, Atashi F, Baisiwala S, Hong Park C. Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma. J Neurosci, 2019, 39: 1982-1993.","journal-title":"J Neurosci"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","volume":"578","author":"Yu K","year":"2020","unstructured":"Yu K, Lin CCJ, Hatcher A, Lozzi B, Kong K, Huang-Hobbs E, Cheng YT. PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis. Nature, 2020, 578: 166-171.","journal-title":"Nature"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","volume":"161","author":"Venkatesh HS","year":"2015","unstructured":"Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell, 2015, 161: 803-816.","journal-title":"Cell"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"Venkatesh HS","year":"2017","unstructured":"Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature, 2017, 549: 533-537.","journal-title":"Nature"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-022-04719-9","volume":"606","author":"Chen P","year":"2022","unstructured":"Chen P, Wang W, Liu R, Lyu J, Zhang L, Li B, Qiu B. Olfactory sensory experience regulates gliomagenesis via neuronal IGF1. Nature, 2022, 606: 550-556.","journal-title":"Nature"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","volume":"594","author":"Pan Y","year":"2021","unstructured":"Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X, Yal\u00e7in B. NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature, 2021, 594: 277-282.","journal-title":"Nature"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conb.2017.10.009","volume":"47","author":"Johung T","year":"2017","unstructured":"Johung T, Monje M. Neuronal activity in the glioma microenvironment. Curr Opin Neurobiol, 2017, 47: 156-161.","journal-title":"Curr Opin Neurobiol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1002\/ijc.33138","volume":"147","author":"Jung E","year":"2020","unstructured":"Jung E, Alfonso J, Monyer H, Wick W, Winkler F. Neuronal signatures in cancer. Intl J Cancer, 2020, 147: 3281-3291.","journal-title":"Intl J Cancer"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.ccell.2025.07.024","volume":"43","author":"Yang Y","year":"2025","unstructured":"Yang Y, Yang C, Chen X, Jiang Y, Lei X, Ma K, Quan Y. Long-range cholinergic input promotes glioblastoma progression. Cancer Cell, 2025, 43: 2089-2105.e10.","journal-title":"Cancer Cell"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1073\/pnas.091113598","volume":"98","author":"Rzeski W","year":"2001","unstructured":"Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA, 2001, 98: 6372-6377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"244ra289","DOI":"10.1126\/scitranslmed.3008065","volume":"6","author":"Pallud J","year":"2014","unstructured":"Pallud J, Le Van Quyen M, Bielle F, Pellegrino C, Varlet P, Labussiere M, Cresto N. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med, 2014, 6:","journal-title":"Sci Transl Med"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/neuonc\/noaf143","volume":"27","author":"Shard C","year":"2025","unstructured":"Shard C, Jones AC, Fouladzadeh A, Palethorpe HM, Francis A, Boyle Y, Ormsby RJ. Novel GABAAR antagonists target networked gene hubs at the leading edge in high-grade gliomas. Neuro-Oncology, 2025, 27: 2943-2958.","journal-title":"Neuro-Oncology"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","volume":"639","author":"Barron T","year":"2025","unstructured":"Barron T, Yal\u00e7in B, Su M, Byun YG, Gavish A, Shamardani K, Xu H. GABAergic neuron-to-glioma synapses in diffuse midline gliomas. Nature, 2025, 639: 1060-1068.","journal-title":"Nature"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ccell.2024.08.009","volume":"42","author":"Curry RN","year":"2024","unstructured":"Curry RN, Ma Q, McDonald MF, Ko Y, Srivastava S, Chin PS, He P. Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma. Cancer Cell, 2024, 42: 1713-1728.e6.","journal-title":"Cancer Cell"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"114410","DOI":"10.1016\/j.biopha.2023.114410","volume":"161","author":"Yang Y","year":"2023","unstructured":"Yang Y, Ren L, Li W, Zhang Y, Zhang S, Ge B, Yang H. GABAergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother, 2023, 161:","journal-title":"Biomed Pharmacother"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm.2453","volume":"17","author":"Buckingham SC","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat Med, 2011, 17: 1269-1274.","journal-title":"Nat Med"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41467-022-30466-6","volume":"13","author":"Anastasaki C","year":"2022","unstructured":"Anastasaki C, Mo J, Chen JK, Chatterjee J, Pan Y, Scheaffer SM, Cobb O. Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. Nat Commun, 2022, 13:","journal-title":"Nat Commun"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/ALN.0000000000002401","volume":"129","author":"Wang C","year":"2018","unstructured":"Wang C, Datoo T, Zhao H, Wu L, Date A, Jiang C, Sanders RD.  Midazolam and dexmedetomidine affect neuroglioma and lung carcinoma cell biology in vitro and in vivo . Anesthesiology, 2018, 129: 1000-1014.","journal-title":"Anesthesiology"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"pbad018","DOI":"10.1093\/pcmedi\/pbad018","volume":"6","author":"Huang Q","year":"2023","unstructured":"Huang Q, Zhou R, Hao X, Zhang W, Chen G, Zhu T. Circulating biomarkers in perioperative management of cancer patients. Precision Clin Med, 2023, 6:","journal-title":"Precision Clin Med"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/iub.2171","volume":"72","author":"Qi Y","year":"2020","unstructured":"Qi Y, Yao X, Du X. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1. IUBMB Life, 2020, 72: 452-464.","journal-title":"IUBMB Life"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuron.2008.11.015","volume":"61","author":"Peng YR","year":"2009","unstructured":"Peng YR, He S, Marie H, Zeng SY, Ma J, Tan ZJ, Lee SY. Coordinated changes in dendritic arborization and synaptic strength during neural circuit development. Neuron, 2009, 61: 71-84.","journal-title":"Neuron"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1038\/s41598-017-03154-5","volume":"7","author":"Balk M","year":"2017","unstructured":"Balk M, Hentschke H, Rudolph U, Antkowiak B, Drexler B. Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices. Sci Rep, 2017, 7:","journal-title":"Sci Rep"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.cell.2019.12.024","volume":"180","author":"Yao M","year":"2020","unstructured":"Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y. Astrocytic trans-differentiation completes a multicellular paracrine feedback loop required for medulloblastoma tumor growth. Cell, 2020, 180: 502-520.e19.","journal-title":"Cell"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"aad3018","DOI":"10.1126\/science.aad3018","volume":"352","author":"Quail DF","year":"2016","unstructured":"Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher AJ, Huse JT, Holland EC. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science, 2016, 352:","journal-title":"Science"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/neuonc\/noaf096","volume":"27","author":"Lee SC","year":"2025","unstructured":"Lee SC, Nakata S, Alaali L, Wang K, Tsai PC, Pham K, Orr BA. BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition. Neuro-Oncology, 2025, 27: 1715-1728.","journal-title":"Neuro-Oncology"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-011-0796-x","volume":"108","author":"Aoki Y","year":"2012","unstructured":"Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD, Gupta N. An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J NeuroOncol, 2012, 108: 29-35.","journal-title":"J NeuroOncol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/neuonc\/now062","volume":"18","author":"Ledur PF","year":"2016","unstructured":"Ledur PF, Liu C, He H, Harris AR, Minussi DC, Zhou HY, Shaffrey ME. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Neuro-Oncology, 2016, 18: 1413-1424.","journal-title":"Neuro-Oncology"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bja.2021.12.042","volume":"128","author":"Oshima Y","year":"2022","unstructured":"Oshima Y, Sano M, Kajiwara I, Ichimaru Y, Itaya T, Kuramochi T, Hayashi E. Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. Br J Anaesth, 2022, 128: 679-690.","journal-title":"Br J Anaesth"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"Love MI","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 2014, 15: 1-2.","journal-title":"Genome Biol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"Kumar L","year":"2007","unstructured":"Kumar L, E Futschik M. Mfuzz: a software package for soft clustering of microarray data. Bioinformation, 2007, 2: 5-7.","journal-title":"Bioinformation"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"Badia-i-Mompel P","year":"2022","unstructured":"Badia-i-Mompel P, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, Taus P. decoupleR: ensemble of computational methods to infer biological activities from omics data. BioInf Adv, 2022, 2:","journal-title":"BioInf Adv"},{"key":"CITATION48","doi-asserted-by":"crossref","unstructured":"Perry B. Shieh AG. Molecular mechanisms underlying activity-dependent regulation of BDNF expression.  J Neurobiol  1999, 41: 127\u2013134 .","DOI":"10.1002\/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","volume":"11","author":"Key TJ","year":"2010","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol, 2010, 11: 530-542.","journal-title":"Lancet Oncol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"Pollak M","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 2008, 8: 915-928.","journal-title":"Nat Rev Cancer"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"Noorolyai S","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene, 2019, 698: 120-128.","journal-title":"Gene"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","volume":"47","author":"Jiang N","year":"2020","unstructured":"Jiang N, Dai Q, Su X, Fu J, Feng X, Peng J. Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior. Mol Biol Rep, 2020, 47: 4587-4629.","journal-title":"Mol Biol Rep"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"He Y","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K\/Akt signal transduction for cancer therapy. Sig Transduct Target Ther, 2021, 6:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.neuron.2018.04.001","volume":"98","author":"Tyssowski KM","year":"2018","unstructured":"Tyssowski KM, DeStefino NR, Cho JH, Dunn CJ, Poston RG, Carty CE, Jones RD. Different neuronal activity patterns induce different gene expression programs. Neuron, 2018, 98: 530-546.e11.","journal-title":"Neuron"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-025-08997-x","volume":"643","author":"Faust Akl C","year":"2025","unstructured":"Faust Akl C, Andersen BM, Li Z, Giovannoni F, Diebold M, Sanmarco LM, Kilian M. Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature, 2025, 643: 219-229.","journal-title":"Nature"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms26072907","volume":"26","author":"Wu J","year":"2025","unstructured":"Wu J, Li R, Wang J, Zhu H, Ma Y, You C, Shu K. Reactive astrocytes in glioma: emerging opportunities and challenges. Int J Mol Sci, 2025, 26:","journal-title":"Int J Mol Sci"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.trecan.2016.12.008","volume":"3","author":"Venkatesh H","year":"2017","unstructured":"Venkatesh H, Monje M. Neuronal activity in ontogeny and oncology. Trends Cancer, 2017, 3: 89-112.","journal-title":"Trends Cancer"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"2001724","DOI":"10.1002\/advs.202001724","volume":"7","author":"Tian A","year":"2020","unstructured":"Tian A, Kang B, Li B, Qiu B, Jiang W, Shao F, Gao Q. Oncogenic state and cell identity combinatorially dictate the susceptibility of cells within glioma development hierarchy to IGF1R targeting. Adv Sci, 2020, 7:","journal-title":"Adv Sci"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"113347","DOI":"10.1016\/j.isci.2025.113347","volume":"28","author":"Li K","year":"2025","unstructured":"Li K, Duan M, Lu Q, Liu J, He M, Zhang Y. Advances in neuroscientific mechanisms and therapies for glioblastoma. iScience, 2025, 28:","journal-title":"iScience"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/neuonc\/nov269","volume":"18","author":"Armstrong TS","year":"2016","unstructured":"Armstrong TS, Grant R, Gilbert MR, Lee JW, Norden AD. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro-Oncology, 2016, 18: 779-789.","journal-title":"Neuro-Oncology"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"e168035","DOI":"10.1172\/JCI168035","volume":"133","author":"Drumm MR","year":"2023","unstructured":"Drumm MR, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb B. Postoperative risk of IDH mutant glioma-associated seizures and their potential management with IDH mutant inhibitors. J Clin Invest, 2023, 133:","journal-title":"J Clin Invest"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s10072-019-04025-9","volume":"40","author":"Maschio M","year":"2019","unstructured":"Maschio M, Aguglia U, Avanzini G, Banfi P, Buttinelli C, Capovilla G, Casazza MML. Management of epilepsy in brain tumors. Neurol Sci, 2019, 40: 2217-2234.","journal-title":"Neurol Sci"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuron.2024.10.016","volume":"113","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Duan W, Chen L, Chen J, Xu W, Fan Q, Li S. Potassium ion channel modulation at cancer-neural interface enhances neuronal excitability in epileptogenic glioblastoma multiforme. Neuron, 2025, 113: 225-243.e10.","journal-title":"Neuron"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"Barr J","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, Ely EW, G\u00e9linas C, Dasta JF, Davidson JE. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med, 2013, 41: 263-306.","journal-title":"Crit Care Med"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","volume":"36","author":"Kienitz R","year":"2022","unstructured":"Kienitz R, Kay L, Beuchat I, Gelhard S, von Brauchitsch S, Mann C, Lucaciu A. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs, 2022, 36: 951-975.","journal-title":"CNS Drugs"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12935-021-02104-6","volume":"21","author":"Sun T","year":"2021","unstructured":"Sun T, Chen J, Sun X, Wang G. Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p\/HOOK3 axis. Cancer Cell Int, 2021, 21:","journal-title":"Cancer Cell Int"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/D9E15C2D12FA4F55908FBB167943E9F3","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026109","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/D9E15C2D12FA4F55908FBB167943E9F3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:07:34Z","timestamp":1790122054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":66,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026109","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}